Posts by: Isaura Santos

Isaura Santos

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

August 19, 2015November 6, 2015

Australian Study Calls For More Inhalable Drugs For Asthmatics, COPD Patients

Asthma, News

People without health concerns don’t think much about breathing, especially given that it is an involuntary action. However, a recent study out of Australia reveals that 1 in 10 people suffer from asthma or other respiratory diseases ... Read more

August 18, 2015November 5, 2015

Cystic Fibrosis Foundation Awards $23M To Fund Research At 11 US Sites

Cystic Fibrosis, News

The Cystic Fibrosis Foundation’s Research Development Program (RDP) recently expanded its network to include two new centers in Atlanta and Denver, which represent two of the largest cystic fibrosis treatment centers in ... Read more

August 17, 2015August 18, 2015

Researchers Discover Better Way To Screen For Lung Cancer

Lung Cancer, News

Researchers at The Valley Hospital recently announced that they are working on paving the way for a much easier, accurate and less invasive method to screen for the most frequent type of lung cancer. Lung cancer is a ... Read more

August 14, 2015November 6, 2015

Go Back To School With The Best Plan To Manage Asthma

Asthma, News

For the 7 million children living with asthma in the United States, preparing for the new school year involves so much more than choosing a new backpack or pencil case. Asthma is the number 3 leading cause for hospitalization among ... Read more

August 12, 2015August 12, 2015

DefiniGEN Licenses Lung Stem Cell Technology From University of Cambridge

News

DefiniGEN Ltd, a worldwide producer of products and services related to stem cell technology, recently announced that its IP portfolio is now much stronger thanks to the addition of a license for a cutting ... Read more

August 11, 2015August 11, 2015

Novavax Announces Data From Phase 2 RSV F-Protein Vaccine Clinical Trial In Older Adults

News

Novavax recently announced positive data from a Phase 2 RSV F-Protein vaccine clinical trial in older adults. The company’s respiratory syncytial virus (RSV) vaccine showed efficacy in the entire population of study subjects, revealing significant vaccine ... Read more

August 11, 2015August 11, 2015

IASLC To Host 2015 World Conference On Lung Cancer

News

The 16th World Conference on Lung Cancer (WCLC) will be held by The International Association for the Study of Lung Cancer (IASLC) from September 6 to 9, 2015 in Denver, Colorado. The ... Read more

August 10, 2015November 5, 2015

Pharmaxis And Synairgen Collaborate To Advance LOXL2 Inhibitor For Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis, News

Australian pharmaceutical company Pharmaxis Ltd and UK based Synairgen plc have signed a research partnership to advance a selective inhibitor for the LOXL2-lysyl oxidase type 2 enzyme in order to treat idiopathic pulmonary fibrosis (IPF), a fatal ... Read more

July 23, 2015November 5, 2015

Access To PARI’s Kitabis Pak CF Therapy Expanded To State Healthcare Programs in U.S.

Cystic Fibrosis, News

PARI, the makers of cystic fibrosis nebulized antibiotic therapy Kitabis Pak, have announced that the product has been added to state healthcare systems across the United States, and now belongs to the Preferred Drug List (PDL) for multiple state ... Read more

July 23, 2015November 5, 2015

Stuart Rich Joins Northwestern Medicine As Director Of Pulmonary Vascular Disease Program

News, Pulmonary Hypertension

Northwestern Medicine recently welcomed Dr. Stuart Rich as director of the new Pulmonary Vascular Disease Program at the Bluhm Cardiovascular Institute, and as a professor of medicine-cardiology at Northwestern University Feinberg School of ... Read more